文献速递血液净化与透析

透析中症状的预测因素:血液透析研究数据分析

Predictors of Intradialytic Symptoms: An Analysis of Data From the Hemodialysis Study.
PubMed 文献 · Am J Kidney Dis · 2020-04-21

该研究基于血液透析试验的前瞻性队列数据(1,838例患者,64,797次透析),旨在识别透析中症状的可变预测因素。随机效应逻辑回归显示,透析前血清尿素氮、超滤率和收缩压下降与不同症状独立相关,而透析前收缩压较高则降低部分症状风险。

要点

  • 透析前血清尿素氮每升高10 mg/dL,肌肉痉挛和头晕的调整OR分别为1.20和1.13。
  • 收缩压下降每增加10 mmHg,肌肉痉挛、头痛、胸痛、呕吐和头晕风险均增加。
  • 超滤率每增加1 mL/kg/h,肌肉痉挛的调整OR为1.03。

核心结论

  • 透析前血清尿素氮水平、超滤率、透析前收缩压及收缩压下降与不同模式的透析中不良症状独立相关。

研究设计与样本

  • 前瞻性队列研究,利用血液透析试验的患者水平数据(n=1,838)和透析会话水平数据(n=64,797)。

主要发现

  • 透析中症状总体发生率为10.7%。
  • 透析前血清尿素氮每升高10 mg/dL,肌肉痉挛和头晕的调整OR分别为1.20(95%CI 1.17-1.22)和1.13(95%CI 1.08-1.18)。
  • 收缩压下降每减少10 mmHg,肌肉痉挛、头痛、胸痛、呕吐和头晕风险增加,其中呕吐和头晕的调整OR最大,分别为1.24(95%CI 1.20-1.28)和1.37(95%CI 1.33-1.42)。
  • 超滤率每增加1 mL/kg/h,肌肉痉挛的调整OR为1.03(95%CI 1.02-1.03)。
  • 透析前收缩压每升高10 mmHg,呕吐和头晕风险降低,调整OR分别为0.88(95%CI 0.85-0.92)和0.82(95%CI 0.80-0.85)。

临床怎么用

  • 识别不同透析中症状的独立预测因素有助于未来干预研究中制定个体化治疗方案。

局限性

  • 缺乏渗透压测量、透析液处方数据和症状发生时间戳。
  • 临床试验数据可能无法广泛推广。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Most patients receiving maintenance hemodialysis (HD) experience adverse symptoms, which are associated with decreased quality of life. Despite decades of experience, our understanding of causes of HD symptoms remains limited. We aimed to identify modifiable patient- and HD-related predictors of intradialytic symptoms. STUDY DESIGN: Prospective cohort. SETTING & PARTICIPANTS: We leveraged patient-level (n=1,838) and HD session-level (n=64,797) data from the Hemodialysis Trial. EXPOSURE: Pre-HD serum urea nitrogen (SUN) level, pre-HD systolic blood pressure (SBP), intradialytic SBP decline, and ultrafiltration rate (UFR). OUTCOMES: Intra-HD symptoms, including cramps, nausea, chest pain, headache, and lightheadedness. ANALYTICAL APPROACH: Random-effects logistic regression models. RESULTS: Overall, symptoms occurred in 10.7% of HD sessions. Higher pre-HD SUN level (per 10 mg/dL) was associated with higher adjusted odds of muscle cramping and lightheadedness (adjusted ORs [aORs] of 1.20 [95% CI, 1.17-1.22] and 1.13 [95% CI, 1.08-1.18], respectively). SBP decline (from the predialysis value to the dialysis session nadir, per each 10-mm Hg decrease) was associated with greater risk for muscle cramping, headache, chest pain, vomiting, and lightheadedness (the largest aORs were for the 2 latter symptoms: 1.24 [95% CI, 1.20-1.28] and 1.37 [95% CI, 1.33-1.42], respectively). Higher UFR (per 1 mL/kg/h) was associated with greater odds of cramping (aOR, 1.03; 95% CI, 1.02-1.03). Conversely, higher pre-HD SBP (per 10 mm Hg) was associated with reduced risk for vomiting (aOR, 0.88; 95% CI, 0.85-0.92) and lightheadedness (aOR, 0.82; 95% CI, 0.80-0.85). LIMITATIONS: Measured osmolality, dialysate prescription data, and time stamps for symptom occurrence were not available. Clinical trial data may not be broadly generalizable. CONCLUSIONS: Higher pre-HD SUN level, UFR, pre-HD SBP, and SBP decline are independently associated with different patterns of adverse intradialytic symptoms. Recognition that different symptoms may have variable causes may allow tailoring of personalized treatments in future interventional studies.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Correa S, Pena-Esparragoza JK, Scovner KM, et al. Predictors of Intradialytic Symptoms: An Analysis of Data From the Hemodialysis Study. Am J Kidney Dis. 2020. PMID: 32331831. doi:10.1053/j.ajkd.2020.01.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。